NCT05901948 is a clinical trial of Classification in Asherman Syndrome, sponsored by Ebtesama Hospital.

Who is sponsoring NCT05901948?

NCT05901948 is sponsored by Ebtesama Hospital.

What drugs are being tested in NCT05901948?

Interventions in NCT05901948: Classification.

What condition does NCT05901948 study?

NCT05901948 studies Asherman Syndrome.

Is NCT05901948 still recruiting?

NCT05901948 is currently completed. Last updated 13 June 2023.

Last reviewed 2023-06-13 · How we verify

NCT05901948

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pre-Surgical Grading System of Asherman Syndrome

Completed Last updated 13 June 2023

What this trial tests

trial testing Classification in Asherman Syndrome in 65 participants. Completed in 15 March 2023.

Timeline

7 January 2020

Primary endpoint
31 January 2023

15 March 2023

Quick facts

Lead sponsor	Ebtesama Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	65
Start date	7 January 2020
Primary completion	31 January 2023
Estimated completion	15 March 2023
Sites	1 location across Egypt

Drugs / interventions tested

Classification

Conditions studied

Asherman Syndrome — all drugs for Asherman Syndrome →

Sponsor

Ebtesama Hospital

Who can join

Adults 20 to 40, female only, with Asherman Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Utilising a novel pre-surgical grading system to class cases of asherman syndrome into 3 groups based on expected difficulty of surgery and potential prognostic outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Classification

Trials testing the same drug.

NCT07424612 — Comparison of Mobile Application and Traditional Methods in Classification · completed
NCT03712059 — National Colorectal Polyp Care · completed

Other recruiting trials for Asherman Syndrome

Currently open trials in the same condition.

NCT04671914 — Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester. · Phase 4 · recruiting

Other Ebtesama Hospital trials

Trials by the same sponsor.

NCT05823103 — New Pre-Surgical Scoring System for Uterine Septum · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05901948 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ebtesama Hospital
Last refreshed: 13 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05901948.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing